The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost

Journal of the American College of Cardiology

Volumn 38, Issue 4, 2001, Pages 1012-1017

  Goldman, Lee ^a   Phillips, Kathryn A ^a,b   Coxson, Pamela ^a   Goldman, Paula A ^c   Williams, Lawrence ^d   Hunink, M G Myriam ^e   Weinstein, Milton C ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY RISK; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEATH; DISEASE MODEL; HABIT; HEALTH CARE COST; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIFESTYLE; MORTALITY; OUTCOMES RESEARCH; POLICY; PREVALENCE; PRIORITY JOURNAL; RESOURCE ALLOCATION; RISK FACTOR; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; COMPUTER SIMULATION; CORONARY DISEASE; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0034814526     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01512-1     Document Type: Article

References (41)

1. The recent decline in mortality from coronary heart disease, 1980-1990
2. Long-term impact of smoking cessation on the incidence of coronary heart disease: Projections of the Coronary Heart Disease Policy Model
3. Trends in mortality, morbidity, and risk factor levels for stroke from 1960 through 1990
4. A prospective study of cholesterol, apolipoproteins, and the risk of MI
5. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality
6. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease
7. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation
8. Cost-effectiveness of population-wide educational approaches to reduce serum cholesterol levels
9. Cholesterol lowering and the use of healthcare resources
10. Cost-effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
11. Forecasting coronary heart disease incidence, mortality, and cost: The Coronary Heart Disease Policy Model
12. Declining serum total cholesterol levels among U.S. adults: The National Health and Nutrition Examination Surveys
13. Are self-reports of smoking rate biased? Evidence from the Second National Health and Nutrition Examination Survey
14. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985: The Minnesota Heart Survey
15. The effect of cost-containment policies on rates of coronary revascularization in California
16. Coronary heart disease and related procedures: National Hospital Discharge Survey data
17. Coronary heart disease in residents of Rochester, Minnesota, V. Prognosis of patients with coronary heart disease based on initial manifestation
18. Quitting smoking in the United States in 1986
19. Methods used to quit smoking in the United States: Do cessation programs help?
20. Use of FDA-approved pharmacologic treatments for tobacco dependence: United States, 1984-1998
21. Independent evaluation of the California tobacco education program
22. A mass media program to prevent smoking among adolescents: Costs and cost effectiveness
23. Health care expenditures for major diseases in 1980
24. Variations in cholesterol management practices of U.S. physicians
25. Direct and indirect economic costs of illness by major diagnosis, U.S.
26. Prescribed use of cholesterol-lowering drugs in the United States, 1978-1988
27. A comparison of economic modeling and clinical trials in the economic evaluation of cholesterol-modifying pharmacotherapy
28. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
29. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels
30. Cost-effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
31. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs
32. The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II Guidelines
33. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2
34. Effect of reduced dietary sodium on blood pressure: A meta-analysis of randomized controlled trials
35. Modeling all-cause mortality: Projections of the impact of smoking cessation based on the NHEFS
36. Evaluation of antismoking advertising campaigns